GB0609465D0 - Pharmaceutically acceptable salts and polymorphic forms - Google Patents

Pharmaceutically acceptable salts and polymorphic forms

Info

Publication number
GB0609465D0
GB0609465D0 GBGB0609465.0A GB0609465A GB0609465D0 GB 0609465 D0 GB0609465 D0 GB 0609465D0 GB 0609465 A GB0609465 A GB 0609465A GB 0609465 D0 GB0609465 D0 GB 0609465D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutically acceptable
acceptable salts
polymorphic forms
polymorphic
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0609465.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Original Assignee
Pliva Hrvatska doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo filed Critical Pliva Hrvatska doo
Priority to GBGB0609465.0A priority Critical patent/GB0609465D0/en
Publication of GB0609465D0 publication Critical patent/GB0609465D0/en
Priority to EP07712850A priority patent/EP2018392A1/en
Priority to CA002649489A priority patent/CA2649489A1/en
Priority to PCT/GB2007/000792 priority patent/WO2007132138A1/en
Priority to EA200870525A priority patent/EA200870525A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0609465.0A 2006-05-12 2006-05-12 Pharmaceutically acceptable salts and polymorphic forms Pending GB0609465D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0609465.0A GB0609465D0 (en) 2006-05-12 2006-05-12 Pharmaceutically acceptable salts and polymorphic forms
EP07712850A EP2018392A1 (en) 2006-05-12 2007-03-06 Pharmaceutically acceptable salts and polymorphic forms
CA002649489A CA2649489A1 (en) 2006-05-12 2007-03-06 Pharmaceutically acceptable salts and polymorphic forms
PCT/GB2007/000792 WO2007132138A1 (en) 2006-05-12 2007-03-06 Pharmaceutically acceptable salts and polymorphic forms
EA200870525A EA200870525A1 (en) 2006-05-12 2007-03-06 PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0609465.0A GB0609465D0 (en) 2006-05-12 2006-05-12 Pharmaceutically acceptable salts and polymorphic forms

Publications (1)

Publication Number Publication Date
GB0609465D0 true GB0609465D0 (en) 2006-06-21

Family

ID=36637404

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0609465.0A Pending GB0609465D0 (en) 2006-05-12 2006-05-12 Pharmaceutically acceptable salts and polymorphic forms

Country Status (5)

Country Link
EP (1) EP2018392A1 (en)
CA (1) CA2649489A1 (en)
EA (1) EA200870525A1 (en)
GB (1) GB0609465D0 (en)
WO (1) WO2007132138A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076483B2 (en) 2006-05-11 2011-12-13 M/S. Ind Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20023574A3 (en) * 2002-10-25 2004-04-14 Léčiva, A.S. New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid

Also Published As

Publication number Publication date
EA200870525A1 (en) 2009-04-28
CA2649489A1 (en) 2007-11-22
WO2007132138A1 (en) 2007-11-22
EP2018392A1 (en) 2009-01-28

Similar Documents

Publication Publication Date Title
HUS000509I2 (en) Abemaciclib or pharmaceutically acceptable salt thereof
DK2035004T3 (en) Phenylsubstituerede pyrazinoylguanidin-natriumkanalblokkere med beta-agonistaktivitet
GB0723131D0 (en) Putter head
ZA200807748B (en) Dihydropyrazolopyrimidinone derivatives
ZA200901336B (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
EP1973405A4 (en) Hydroxyalkylarylamide derivatives
IL198319A0 (en) Spiroindolinone derivatives
GB0606234D0 (en) Pharmaceutically acceptable salts and polymorphic forms
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
GB0723132D0 (en) Putter head
HK1136276A1 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2-
IL193211A0 (en) Indazole-heteroaryl derivatives
IL206479A0 (en) Crystalline forms of palonosetron hydrochloride
EP2043633A4 (en) Thiadiazolidinone derivatives
GB0600749D0 (en) Pharmaceutically acceptable co-crystalline forms
GB0613928D0 (en) Pharmaceutically acceptable salt and polymorphic forms
IL197239A0 (en) Phenyloxyaniline derivatives
ZA200807460B (en) Spiroindolinone derivatives
GB0605344D0 (en) Pharmaceutically acceptable salts and polymorphic forms
GB0519891D0 (en) Pharmaceutically acceptable salts and hydrates